<?xml version="1.0" encoding="UTF-8"?>
<sec id="Sec26" class="sec">
 <div class="title" xmlns="http://www.w3.org/1999/xhtml">Determination of the mechanism underlying the vasorelaxant activity of AcEO</div>
 <sec id="Sec27" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Vasorelaxant effect of AcEO on denuded aorta, and on intact aorta preincubated with Atropine and Calmidazolium</div>
  <p xmlns="http://www.w3.org/1999/xhtml">AcEO (0.1–100 μg/ml) abolished the contraction induced by phenylephrine on intact thoracic aorta, and induced 95.97% ± 2.03 of vasorelaxation. The vasorelaxant effect induced by AcEO on denuded aorta (102.07% ± 3.01; 
   <span class="italic">p</span> &gt; 0.05), also, the pretreatment with calmidazolium (97.07% ± 3.29; 
   <span class="italic">p</span> &gt; 0.05), blocker of calcium-calmodulin binding to NO synthase, did not affect the vasorelaxation induced by AcEO. However, the vasorelaxation provoked by AcEO on aorta precontracted with phenylephrine has been partially inhibited, when preincubated with the muscarinic receptor inhibitor, atropine (85.69% ± 6.56; 
   <span class="italic">p</span> &lt; 0.05) (Fig. 
   <a rid="Fig5" ref-type="fig" href="#Fig5">5a</a>).
   <div id="Fig5" class="fig">
    <span class="label">Fig. 5</span>
    <div class="caption">
     <p>Concentration–response curves of the vasorelaxant effect of 
      <span class="italic">A. campestris</span> L. (AcEO) on (
      <span class="bold">a</span>) isolated aorta pre-contracted with phenylephrine 10
      <span class="sup">−6</span> M, on denuded aorta and on aorta pre-incubated with Atropine and Calmidazolium, (
      <span class="bold">b</span>) with L-NAME, Hydroxocobalamin, ODQ and 8-RP-Br-PET-cGMP. Values are mean ± SEM, 
      <span class="italic">n</span> = 6, and analyzed with two way ANOVA followed by Bonferroni’s post-test; * 
      <span class="italic">p</span> &lt; 0.05 vs control
     </p>
    </div>
    <div xlink:href="12906_2017_1598_Fig5_HTML" id="MO5" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </div>
  </p>
 </sec>
 <sec id="Sec28" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Vasorelaxant effect of AcEO on aorta preincubated with L-NAME, Hydroxycobalamin, ODQ and 8-RP-Br-PET-cGMP</div>
  <p xmlns="http://www.w3.org/1999/xhtml">No significant difference on the vasorelaxation effect of AcEO (0.1–100 μg/ml) on phenylephrine precontracted aorta have been observed in the presence of NO synthase inhibitor; L-NAME (97.27% ± 2.82; 
   <span class="italic">p</span> &gt; 0.05), in the presence of NO scavenger; hydroxocobalamin (93.99% ± 2.32; 
   <span class="italic">p</span> &gt; 0.05), and in the presence of guanylyl cyclase inhibitor; ODQ (92.26% ± 3.91; 
   <span class="italic">p</span> &gt; 0.05). However, relative inhibitory effect AcEO-induced vasorelaxation have been observed in the presence of the competitive cGMP-dependent protein kinase G (PKG) inhibitor; Rp-8-Br-PET-cGMP (87.86% ± 4.28; 
   <span class="italic">p</span> &lt; 0.05) (Fig. 
   <a rid="Fig5" ref-type="fig" href="#Fig5">5b</a>).
  </p>
 </sec>
 <sec id="Sec29" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Vasorelaxant effect of AcEO on aorta preincubated with potassium channels blockers, TEA, 4-AP, BaCl2 and Glybenclamide</div>
  <p xmlns="http://www.w3.org/1999/xhtml">Pretreatment of aorta with potassium channels blockers; TEA (98.91% ± 3, 73; 
   <span class="italic">p</span> &gt; 0.05), 4-AP (98.05% ± 2.96; 
   <span class="italic">p</span> &gt; 0.05), BaCl
   <sub>2</sub> (103.52% ± 2.47; p &gt; 0.05) and glybenclamide (99.55% ± 2.66; 
   <span class="italic">p</span> &gt; 0.05), showed no significant changes in AcEO (0.1–100 μg/ml) induced-vasorelaxation (Fig. 
   <a rid="Fig6" ref-type="fig" href="#Fig6">6a</a>).
   <div id="Fig6" class="fig">
    <span class="label">Fig. 6</span>
    <div class="caption">
     <p>Concentration–response curves of the vasorelaxant effect of 
      <span class="italic">A. campestris</span> L. (AcEO) on (
      <span class="bold">a</span>) isolated aorta pre-contracted with Phen 1 μM, and in the presence of TEA, 4-AP, BaCl
      <sub>2</sub> and Glibenclamide, and in the presence of (
      <span class="bold">b</span>) Thapsigargin, Verapamil and Indomethacin. Values are mean ± SEM, 
      <span class="italic">n</span> = 6, and analyzed with two way ANOVA followed by Bonferroni’s post-test; *** 
      <span class="italic">p</span> &lt; 0.001 vs control
     </p>
    </div>
    <div xlink:href="12906_2017_1598_Fig6_HTML" id="MO6" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </div>
  </p>
 </sec>
 <sec id="Sec30" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Vasorelaxant effect of AcEO on aorta preincubated with Indomethacin, Thapsigargin and Verapamil</div>
  <p xmlns="http://www.w3.org/1999/xhtml">Pretreatment of aorta with cyclooxygenase inhibitor; indomethacin (92.95% ± 2.73; 
   <span class="italic">p</span> &gt; 0.05) did not produce any significant difference of vasorelaxation induced by AcEO precontracted with phenylephrine. Therefore, aorta preincubated with endoplasmic reticulum calcium-ATPase inhibitor; thapsigargin (45.34% ± 6.58; 
   <span class="italic">p</span> &lt; 0.001), and calcium channel type VOC blocker; verapamil (48.12% ± 8.21; 
   <span class="italic">p</span> &lt; 0.001) produced a sub-maximum inhibitory effect of vasorelaxation induced by AcEO (0.1–100 μg/ml) (Figs. 
   <a rid="Fig6" ref-type="fig" href="#Fig6">6b</a> and 
   <a rid="Fig7" ref-type="fig" href="#Fig7">7</a>).
   <div id="Fig7" class="fig">
    <span class="label">Fig. 7</span>
    <div class="caption">
     <p>Original tracing showing the vasorelaxant effect of 
      <span class="italic">A. campestris</span> L. essential oil (AcEO) on isolated aorta pre-contracted with Phen 1 μM (
      <span class="bold">a</span>) and in the presence of Verapamil (
      <span class="bold">b</span>) and Thapsigargin (
      <span class="bold">c</span>)
     </p>
    </div>
    <div xlink:href="12906_2017_1598_Fig7_HTML" id="MO7" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </div>
  </p>
 </sec>
 <sec id="Sec31" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Vasorelaxant effect of AcEO on aorta precontracted with Phen (1 μM) and K
   <span class="sup">+</span> (80 mM) and comparative vasorelaxant effect of cumulative doses of ACEO and Verapamil on K
   <span class="sup">+</span> (80 mM)
  </div>
  <p xmlns="http://www.w3.org/1999/xhtml">As shown in Fig. 
   <a rid="Fig8" ref-type="fig" href="#Fig8">8</a>, AcEO triggered a concentration-dependent vasodilation against Phen (1 μM) and K
   <span class="sup">+</span> (80 mM) induced vasocontractions, with respective EC
   <sub>50</sub> value of 0.005 mg/ml (
   <span class="italic">n</span> = 6) and 0.019 mg/ml (
   <span class="italic">n</span> = 6). In parallel, AcEO and verapamil administered in increasing doses to the plateau of K
   <span class="sup">+</span> (80 mM), showed a similar vasorelaxant profile with respective E
   <sub>max</sub> values of (97,04% + 4,08; 
   <span class="italic">n</span> = 6) and (94,97% + 3,35; 
   <span class="italic">n</span> = 6) (Fig. 
   <a rid="Fig9" ref-type="fig" href="#Fig9">9</a>).
   <div id="Fig8" class="fig">
    <span class="label">Fig. 8</span>
    <div class="caption">
     <p>The originaltrcing (
      <span class="bold">a</span>) and the concentration–response curves (
      <span class="bold">b</span>) of the vasorelaxant effect of 
      <span class="italic">A. campestris</span> L. essential oil (AcEO) on Phen (1 μM) and on K
      <span class="sup">+</span> (80 mM)-induced contraction. Values are mean ± SEM, 
      <span class="italic">n</span> = 6, and analyzed with non linear regression test
     </p>
    </div>
    <div xlink:href="12906_2017_1598_Fig8_HTML" id="MO8" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </div>
   <div id="Fig9" class="fig">
    <span class="label">Fig. 9</span>
    <div class="caption">
     <p>The original tracing (
      <span class="bold">a</span>) and the concentration–response curves (
      <span class="bold">b</span>) of the vasorelaxant effect of 
      <span class="italic">A. campestris</span> L. essential oil (AcEO) and Verapamil on K
      <span class="sup">+</span> (80 mM)-induced contraction. Values are mean ± SEM, 
      <span class="italic">n</span> = 6, and analyzed with linear regression test
     </p>
    </div>
    <div xlink:href="12906_2017_1598_Fig9_HTML" id="MO9" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </div>
  </p>
 </sec>
</sec>
